Lates News

The developer of anti-obesity drugs Metsera's stock surged more than 47% before the market opening, reportedly Pfizer is close to acquiring the company for $7.3 billion; Asmei's stock rose nearly 3%, and Morgan Stanley significantly raised its target price from 600 euros to 950 euros.